Friday at a glance: the consumer lifestyle brand developer went up to $3.8, gaining 7.04%.
United States ISM Non-Manufacturing PMI (Nov) is next today at 15:00 UTC.
Visual analysis of Cresco Labs's chart shows that Cresco Labs Inc. is 17 cents away from testing key resistance at $3.97. Peaking above this level could inspire market bulls and open the path to further gains. With regards to technical trend indicators, chart analysis show that investors are seeking long positions as Cresco Labs price action surged above +100 — a key CCI threshold indicating an imminent bullish trend. Analysis based on the asset volatility indicates that Bollinger Band® analysis indicates that current price action is approaching the upper band at $3.76, thereby suggesting that Cresco Labs is becoming overvalued.
Notwithstanding Cresco Labs's appreciation in recent days, the technical outlook suggests its bullish run is now fading.
A look at other health care stocks also showed bullish price action as AbbVie added 1.26% to its value, and traded at $163.66. Eli Lilly and Company was up 1.2%.
While Cresco Labs was bullish Friday, the following health care stocks underperformed: Sanofi went down to $45, losing 1.87% after it closed at $45.87 Friday.
Furthermore, the market is looking at United States ISM Non-Manufacturing PMI (Nov) is expected today at 15:00 UTC. United States EIA Short-Term Energy Outlook scheduled to come out tomorrow at 17:00 UTC.
Having set a significant high of $8.13 2 months ago, the medical marijuana company is trading 45.49% lower.